Drug Markets/Ertapenem

Ertapenem

6 NDCs across 5 manufacturers|6 Generic,0 Brand

Ertapenem is used to treat abdominal abscess, bacteroides infections, escherichia coli infections, haemophilus infections, intraabdominal infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Ertapenem is available as 6 NDCs from 5 manufacturers (6 generic, 0 brand), with NADAC prices from $27.76 to $27.76 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

6G / 0B

Manufacturers

5

competing in market

Price Spread

$27.76 – $27.76

per EA

7d Activity

60 flat

avg -8.3% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Ertapenem used to treat?

Ertapenem is used to treat abdominal abscess, bacteroides infections, escherichia coli infections, haemophilus infections, intraabdominal infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.

How many Ertapenem products are on the market?

The Ertapenem drug market contains 6 NDCs from 5 manufacturers — 6 generic and 0 brand products.

What is the price range for Ertapenem?

NADAC reference prices for Ertapenem range from $27.7551 to $27.7551 per EA.

Which manufacturers make Ertapenem?

5 manufacturers list Ertapenem in NADAC. Ranked by number of NDCs, the largest are Eugia US LLC (2), Hospira Inc. (1), NorthStar Rx LLC (1), Dr. Reddy's Laboratories Inc. (1), WG Critical Care, LLC (1).

How has the price of Ertapenem changed recently?

Over the past 7 days, 0 Ertapenem NDCs rose and 6 fell, with a market-wide average change of -8.3%.